Cited 0 times in
Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 육종인 | - |
dc.contributor.author | 최지원 | - |
dc.date.accessioned | 2021-09-29T00:35:38Z | - |
dc.date.available | 2021-09-29T00:35:38Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/183939 | - |
dc.description.abstract | Recent findings indicate that (a) mitochondria in proliferating cancer cells are functional, (b) cancer cells use more oxygen than normal cells for oxidative phosphorylation, and (c) cancer cells critically rely on cytosolic NADH transported into mitochondria via the malate-aspartate shuttle (MAS) for ATP production. In a spontaneous lung cancer model, tumor growth was reduced by 50% in heterozygous oxoglutarate carrier (OGC) knock-out mice compared with wild-type counterparts. To determine the mechanism through which OGC promotes tumor growth, the effects of the OGC inhibitor N-phenylmaleimide (NPM) on mitochondrial activity, oxygen consumption, and ATP production were evaluated in melanoma cell lines. NPM suppressed oxygen consumption and decreased ATP production in melanoma cells in a dose-dependent manner. NPM also reduced the proliferation of melanoma cells. To test the effects of NPM on tumor growth and metastasis in vivo, NPM was administered in a human melanoma xenograft model. NPM reduced tumor growth by approximately 50% and reduced melanoma invasion by 70% at a dose of 20 mg/kg. Therefore, blocking OGC activity may be a useful approach for cancer therapy. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | PHARMACEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production | - |
dc.type | Article | - |
dc.contributor.college | College of Dentistry (치과대학) | - |
dc.contributor.department | Dept. of Oral Pathology (구강병리학교실) | - |
dc.contributor.googleauthor | Jae-Seon Lee | - |
dc.contributor.googleauthor | Jiwon Choi | - |
dc.contributor.googleauthor | Seon-Hyeong Lee | - |
dc.contributor.googleauthor | Joon Hee Kang | - |
dc.contributor.googleauthor | Ji Sun Ha | - |
dc.contributor.googleauthor | Hee Yeon Kim | - |
dc.contributor.googleauthor | Hyonchol Jang | - |
dc.contributor.googleauthor | Jong In Yook | - |
dc.contributor.googleauthor | Soo-Youl Kim | - |
dc.identifier.doi | 10.3390/pharmaceutics12111128 | - |
dc.contributor.localId | A02536 | - |
dc.relation.journalcode | J02504 | - |
dc.identifier.eissn | 1999-4923 | - |
dc.identifier.pmid | 33238375 | - |
dc.subject.keyword | ATP production | - |
dc.subject.keyword | cancer metabolism | - |
dc.subject.keyword | malate-aspartate shuttle | - |
dc.subject.keyword | oxoglutarate carrier | - |
dc.contributor.alternativeName | Yook, Jong In | - |
dc.contributor.affiliatedAuthor | 육종인 | - |
dc.citation.volume | 12 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1128 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICS, Vol.12(11) : 1128, 2020-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.